Bio-Rad Laboratories, Inc. logo
Bio-Rad Laboratories, Inc. (BIO)
Compare

Bio-Rad Laboratories, Inc. (BIO) Operating Margin: 9.25%

Is Bio-Rad Laboratories, Inc.’s operating margin high or low?

Bio-Rad Laboratories, Inc.'s operating margin of 9.25% is 34% below its 5-year average of 14.08%, near the low end of its 5-year range (10.47%–17.22%).

The operating margin for Bio-Rad Laboratories, Inc. (BIO) is 9.25% as of Wednesday, June 10, 2026. It is below its 12-month average by 11.69% (10.48%).

BIO Operating Margin Chart

BIO Operating Margin
10.47%-0.10% 1Y
Zoom

BIO Average Operating Margin Chart

BIO Current vs Average Operating Margin Chart

BIO Operating Margin Metrics

OPERATING MARGIN

9.25%

OPERATING MARGIN AVG TTM

10.48%

OPERATING MARGIN AVG 3Y

12.70%

OPERATING MARGIN AVG 5Y

14.08%

OPERATING MARGIN AVG 10Y

9.63%

OPERATING MARGIN AVG 15Y

10.16%

OPERATING MARGIN AVG 20Y

10.30%

CURRENT VS TTM AVG

-11.69%

CURRENT VS 3Y AVG

-27.19%

CURRENT VS 5Y AVG

-34.31%

CURRENT VS 10Y AVG

-3.93%

CURRENT VS 15Y AVG

-8.92%

CURRENT VS 20Y AVG

-10.19%

BIO Competitors' Operating Margin

NAMEMARKET CAPOPERATING MARGINTTM3Y5Y
Bio-Rad Laboratories, Inc. (BIO)$7.89B9.25%10.48%12.70%14.08%
Charles River Laboratories International, Inc. (CRL)$9.06B11.77%9.13%12.39%13.51%
Hims & Hers Health, Inc. (HIMS)$6.42B1.32%4.35%-1.93%-10.04%
Baxter International Inc. (BAX)$10.49B-2.65%-1.31%-6.02%0.15%
Align Technology, Inc. (ALGN)$12.56B14.44%15.23%16.08%17.45%
Hologic, Inc. (HOLX)$16.97B17.49%19.66%22.41%27.16%
Moderna, Inc. (MRNA)$18.40B-153.35%-140.72%-73.36%-52.24%
BioNTech SE (BNTX)$21.81B-51.55%-35.20%5.18%14.03%
Mettler-Toledo International Inc. (MTD)$22.85B28.00%28.45%28.53%27.71%
Waters Corporation (WAT)$23.83B17.08%28.07%28.30%28.33%

Operating Efficiency

Gross Margin

51.9%

Operating Margin

9.3%

Bio-Rad Laboratories, Inc. Operating Margin Formula & Definition

Operating Margin = Operating Income / Revenue

Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Bio-Rad Laboratories, Inc. Operating Margin FAQ

What is the operating margin for Bio-Rad Laboratories, Inc. (BIO)?
The operating margin for BIO stock is 9.25%.
Is Bio-Rad Laboratories, Inc.'s operating margin high or low?
Bio-Rad Laboratories, Inc.'s operating margin of 9.25% is 34% below its 5-year average of 14.08%, near the low end of its 5-year range (10.47%–17.22%).
What is the TTM average operating margin for Bio-Rad Laboratories, Inc. (BIO)?
The TTM average operating margin for BIO stock is 10.48%.
What is the 3Y average operating margin for Bio-Rad Laboratories, Inc. (BIO)?
The 3Y average operating margin for BIO stock is 12.70%.
What is the 5Y average operating margin for Bio-Rad Laboratories, Inc. (BIO)?
The 5Y average operating margin for BIO stock is 14.08%.
What is the 10Y average operating margin for Bio-Rad Laboratories, Inc. (BIO)?
The 10Y average operating margin for BIO stock is 9.63%.
What is the 15Y average operating margin for Bio-Rad Laboratories, Inc. (BIO)?
The 15Y average operating margin for BIO stock is 10.16%.
What is the 20Y average operating margin for Bio-Rad Laboratories, Inc. (BIO)?
The 20Y average operating margin for BIO stock is 10.30%.

Bio-Rad Laboratories, Inc. Operating Margin History

DATEOPERATING MARGIN
2025-12-3110.47%
2024-12-3110.48%
2023-12-3112.65%
2022-12-3117.22%
2021-12-3117.12%
2020-12-3116.55%
2019-12-319.93%
2018-12-31-4.74%
2017-12-315.40%
2016-12-312.57%
2015-12-318.26%
2014-12-316.90%
2013-12-317.95%
2012-12-3112.76%
2011-12-3114.23%
2010-12-3114.74%
2009-12-3112.95%
2008-12-3110.37%
2007-12-319.25%
2006-12-3111.47%
2005-12-319.76%
2004-12-319.99%
2003-12-3114.53%
2002-12-3115.39%
2001-12-3113.70%
2000-12-319.20%
1999-12-318.84%
1998-12-317.02%
1997-12-316.23%
1996-12-319.96%

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA
7,700 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz